Afatinib dimaleate is an anti-cancer medication. It works by binding and inhibiting the enzyme receptors (EGFR, HER2, and HER4) that are responsible for the growth of cancer cells. Hence, resulting in the downregulation of signaling pathways
Just one more step!
Login first,to proceed further.
Send Enquiry